钧崴电子科技股份有限公司 2025 年第三季度报告 证券代码：301458 证券简称：钧崴电子 公告编号：2025-048 钧崴电子科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 钧崴电子科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 218,698,074.49 | 20.02% | 573, ...

上海凯利泰医疗科技股份有限公司 2025 年第三季度报告 证券代码：300326 证券简称：ST 凯利 公告编号：2025-106 上海凯利泰医疗科技股份有限公司 2025 年第三季度报告 股票代码：300326 股票简称：ST 凯利 披露日期：二○二五年十月二十二日 上海凯利泰医疗科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 上海凯利泰医疗科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 241,862,293.98 | -11.84% | 787,958,9 ...

Financial Performance - The company's operating revenue for Q3 2025 reached ¥968.93 million, an increase of 26.68% compared to the same period last year[2] - The total profit for the quarter was ¥254.73 million, reflecting a decrease of 9.08% year-over-year[2] - Net profit attributable to shareholders was ¥238.23 million, down 4.63% from the previous year[2] - The basic earnings per share for the quarter was ¥0.59, a decrease of 3.28% compared to the same period last year[2] - Total revenue for the first three quarters of 2025 reached CNY 2,479,547,947.46, a 26.7% increase from CNY 1,954,701,664.76 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was CNY 666,123,781.87, representing a 20.2% increase compared to CNY 554,149,217.81 in 2024[20] - Basic and diluted earnings per share for the first three quarters of 2025 were CNY 1.64, up from CNY 1.36 in the same period of 2024[21] Research and Development - Research and development expenses totaled ¥109.54 million, an increase of 22.90% year-over-year, representing 11.31% of operating revenue[3] - Research and development expenses for the first three quarters of 2025 totaled CNY 279,335,347.75, an increase of 44.5% from CNY 193,341,950.18 in 2024[20] Assets and Liabilities - Total assets at the end of the quarter were ¥3.79 billion, a 24.12% increase from the end of the previous year[3] - Total assets as of the reporting date were CNY 3,786,248,215.19, compared to CNY 3,050,414,835.58 in the previous year[18] - Total liabilities increased to CNY 776,988,289.04 from CNY 497,098,543.83 year-over-year[18] - Non-current assets totaled CNY 1,551,638,564.12, up from CNY 1,223,324,670.50 in the previous year[18] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥471.12 million, an increase of 61.33%[3] - Cash flow from operating activities for the first three quarters of 2025 was CNY 2,454,222,650.87, compared to CNY 1,895,427,035.95 in 2024[23] - Net cash flow from operating activities amounted to ¥471,118,206.70, an increase from ¥292,015,044.33 year-over-year[24] - Cash inflow from investment activities totaled ¥1,047,660,067.17, compared to ¥548,482,799.76 in the previous period[24] - Net cash flow from financing activities was -¥83,917,940.47, a decrease from -¥171,371,528.22 year-over-year[25] Shareholder Information - The company reported a total of 8,608 common shareholders at the end of the reporting period[8] - Major shareholder Yang Ying holds 33.94% of the shares, with a total of 138,077,266 shares[8] Current Assets - As of September 30, 2025, the company's total current assets amounted to RMB 2,234,609,651.07, an increase from RMB 1,827,090,165.08 as of December 31, 2024, reflecting a growth of approximately 22.3%[16] - The company's cash and cash equivalents increased to RMB 449,450,206.30 from RMB 371,821,698.43, representing a growth of about 20.9%[16] - Accounts receivable rose to RMB 788,908,929.03 from RMB 771,496,539.39, indicating a slight increase of approximately 2.3%[16] - Inventory levels increased to RMB 374,644,060.24 from RMB 263,546,426.51, marking a significant rise of around 42.2%[16] Donations and Community Projects - The company has committed to additional donations totaling RMB 8 million for various hepatitis-related projects, with RMB 600,000 already donated during the reporting period[11] - The company has donated RMB 540,000 to the "Oasis Project" aimed at reducing liver cancer incidence among hepatitis patients, with total donations reaching RMB 3,370,000 to date[12] - The company has pledged RMB 900,000 for HBV-related liver cancer prevention projects, with RMB 200,000 donated so far[13] - The company has also committed RMB 1 million to the "Little Bamboo Shoot" children's health project, with RMB 250,000 already contributed[13] Fixed Assets - The company’s fixed assets increased to RMB 608,598,977.21 from RMB 496,526,291.01, reflecting a growth of approximately 22.5%[16] - The company’s construction in progress rose to RMB 267,704,214.37 from RMB 181,556,607.69, indicating an increase of about 47.5%[16]

Financial Performance - The company's operating revenue for Q3 2025 was ¥49,358,147.05, representing a 5.90% increase year-over-year[7] - Net profit attributable to shareholders decreased by 25.14% to ¥2,710,058.35 in Q3 2025, while year-to-date net profit increased by 78.52% to ¥9,044,713.76[7] - The net profit after deducting non-recurring gains and losses for Q3 2025 was ¥1,838,537.11, an increase of 18.68% compared to the same period last year[7] - The basic and diluted earnings per share for Q3 2025 were both ¥0.0277, a decrease of 23.48% year-over-year[7] - The total profit for the period reached CNY 9,531,268.05, an increase of 203.42% compared to CNY 3,141,242.19 in the previous period[12] - Net profit attributable to shareholders was CNY 9,044,713.76, up 78.52% from CNY 5,066,531.44 in the same period last year[12] - The net profit for the third quarter of 2025 was CNY 7,194,343.51, an increase of 134.7% compared to CNY 3,074,727.38 in the same period last year[26] - Operating profit reached CNY 9,683,882.76, compared to CNY 3,049,030.59, marking an increase of 217.5%[26] - The total comprehensive income for the third quarter was CNY -30,277,817.29, a decline from CNY 2,963,041.06 in the same period last year[26] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥1,030,058,881.99, down 15.15% from the end of the previous year[7] - Cash and cash equivalents at the end of the period amounted to CNY 238,097,625.10, a 160.56% increase from CNY 91,379,154.66[13] - The company's total assets decreased to ¥1,030,058,881.99 from ¥1,214,001,925.74, a decline of approximately 15.1%[24] - Current liabilities decreased significantly to ¥64,076,178.02 from ¥207,886,974.07, a reduction of about 69.1%[24] - The total equity attributable to shareholders decreased to ¥974,548,591.87 from ¥1,012,972,038.91, a decline of approximately 3.8%[24] Cash Flow - The company's cash flow from operating activities for the year-to-date period increased by 105.13% to ¥19,815,296.96[7] - Operating cash flow net amount increased by 105.13% to CNY 19,815,296.96, compared to CNY 9,660,095.36 in the previous year[12] - Cash flow from operating activities generated a net amount of CNY 19,815,296.96, significantly higher than CNY 9,660,095.36 from the previous year, representing a growth of 105.5%[27] - Cash flow from investment activities yielded a net inflow of CNY 14,046,124.40, a turnaround from a net outflow of CNY -17,534,940.84 in the same period last year[27] - The company reported a decrease in cash flow from financing activities, with a net outflow of CNY -10,894,341.24 compared to CNY -90,404,351.11 in the previous year[28] Investments - The company reported a significant increase in long-term equity investments by 667.10% to ¥120,688,791.24 due to investments in Shanghai Pidong Cultural Media Co., Ltd.[11] - The company acquired a 39.00% stake in Shanghai PIDONG Cultural Media Co., Ltd. for a total investment of RMB 102.30 million through the purchase of existing shares and capital increase[19] - The investment aims to enhance the company's IP and productization business, focusing on the creation and sales of cultural products and IP derivatives[19] - The company’s investment strategy focuses on expanding its IP business through strategic acquisitions and partnerships in the cultural and entertainment sectors[19] - The company aims to leverage synergies from the investment in Shanghai PIDONG to further develop its IP business and product offerings[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,098, with no preferred shareholders[14] - The company reported a total of 25,938,375 shares held by major shareholders, with significant holdings by 泰州汉仪天下投资中心 (17,086,425 shares) and 泰州汉之源企业管理咨询合伙企业 (1,509,075 shares)[18] - The company’s major shareholders include individuals and investment funds, with the top 10 shareholders holding a combined total of 25,938,375 shares[18] - The company’s shareholder谢立群 had 7,342,875 shares, with 5,507,156 shares released from lock-up during the reporting period[18] - The company’s stock structure includes various private equity funds, with significant holdings from 上海阿杏投资管理有限公司 and 上海烜鼎私募基金管理有限公司[17] - The company has not reported any changes in the lending or borrowing of shares among its top shareholders during the reporting period[17] Expenses - The company’s financial expenses decreased by 65.79% to -¥412,668.50, attributed to reduced interest income from bank deposits[11] - Research and development expenses were ¥27,200,412.49, down from ¥32,887,672.84, indicating a decrease of about 17.3%[25] - The company reported a significant decrease in credit impairment losses, down 35.37% to CNY 155,166.23 due to improved accounts receivable collection[12] - The company recorded a 3413.39% increase in income tax expenses, totaling CNY 2,336,924.54, driven by the increase in total profit[12] - Other comprehensive income attributable to shareholders decreased significantly by 673.73% to CNY -28,427,447.04, primarily due to changes in fair value of other equity instruments[12] Market Strategy - The company is focusing on market expansion and new product development strategies to enhance future growth prospects[25]

Financial Performance - The company's revenue for Q3 2025 was ¥98,552,951.54, a decrease of 6.36% compared to the same period last year[4]. - Net profit attributable to shareholders was ¥3,015,658.87, down 83.02% year-on-year[4]. - The basic earnings per share decreased to ¥0.0186, reflecting an 83.00% decline compared to the previous year[4]. - Total revenue for the current period was ¥257,613,224.35, a decrease of approximately 19.7% compared to ¥320,918,983.86 in the previous period[24]. - In Q3 2025, the company's net profit was CNY 2,839,782.28, a significant decrease from CNY 19,767,610.53 in the same period last year, representing a decline of approximately 85.6%[25]. - The total comprehensive income for the period was CNY 3,060,471.70, down from CNY 19,996,771.99, indicating a decrease of approximately 84.7%[25]. - The company reported a total profit of CNY 3,117,944.68, down from CNY 22,531,669.75, reflecting a decrease of approximately 86.2%[25]. Assets and Liabilities - Total assets increased by 14.40% to ¥2,000,760,511.63 compared to the end of the previous year[4]. - Total assets rose to ¥2,000,760,511.63 from ¥1,748,986,409.73, marking an increase of approximately 14.4%[23]. - Total liabilities increased to ¥472,836,217.37 from ¥230,944,723.47, reflecting a significant rise of about 105.5%[22]. - Non-current liabilities grew to ¥386,085,378.67 from ¥99,787,476.32, indicating an increase of approximately 287.5%[22]. - The company's equity attributable to shareholders decreased to ¥1,471,072,927.99 from ¥1,507,492,840.59, a decline of about 2.4%[23]. Cash Flow - The company reported a net cash flow from operating activities of ¥103,104,566.22, a decrease of 7.30% year-to-date[11]. - The company reported a net cash flow from operating activities of CNY 103,104,566.22, compared to CNY 111,225,112.81 in the previous year, reflecting a decline of approximately 7.5%[27]. - Investment activities resulted in a net cash outflow of CNY 222,966,441.49, slightly improved from a net outflow of CNY 242,800,556.74 in the prior year[27]. - The company raised CNY 271,863,103.00 through borrowings, a significant increase from CNY 76,046,404.55 in the previous year, marking an increase of approximately 257.5%[27]. - Cash and cash equivalents increased to ¥395,652,885.52 from ¥308,738,859.31, representing a growth of about 28.1%[21]. - The company's cash and cash equivalents at the end of the period increased to CNY 390,472,485.52 from CNY 269,290,121.50, representing an increase of about 45.0%[27]. Borrowings and Financing - The company experienced a significant increase in short-term borrowings, rising by 84.76% to ¥11,073,759.16 due to the consolidation of subsidiary short-term loans[9]. - The company's short-term borrowings increased to ¥11,073,759.16 from ¥5,993,515.26, representing an increase of approximately 84.7%[22]. - The company’s cash flow from financing activities increased by 911.24% to ¥213,108,193.15, primarily due to cash received from acquisition financing[11]. Shareholder Information - Major shareholders include Ying Er Yao with 20.15% and Lingfei Group with 7.40% of shares[14]. - The company repurchased a total of 737,000 shares, accounting for 0.45% of the total share capital, with a total payment of RMB 20,026,948.40[18]. - The highest repurchase price during the buyback was RMB 29.34 per share, while the lowest was RMB 23.89 per share[18]. - The company has a plan to use the repurchased shares for employee stock ownership plans[18]. - The company has a total of 2,683,150 shares held in a repurchase special account as of the reporting period[14]. - The company has not disclosed any other related party relationships among the top 10 shareholders[17]. - The company has not reported any changes in the lending of shares by major shareholders due to margin trading[15]. Mergers and Acquisitions - The company plans to acquire 82.00% of Wuhan Kanglu Biotechnology Co., Ltd. in a transaction totaling RMB 328 million, to be completed in three phases from 2025 to 2027[19][20]. - As of the reporting period, the company has completed the share transfer for 2025, and Kanglu Biotechnology has been integrated into the company's consolidated financial statements[20]. - The company’s goodwill reached ¥188,489,219.38, attributed to mergers and acquisitions[8]. Operating Costs and Expenses - Total operating costs decreased to ¥237,122,494.65 from ¥287,293,766.22, reflecting a reduction of about 17.5%[24]. - Research and development expenses were ¥39,990,947.86, down from ¥49,460,725.22, indicating a decrease of approximately 19.9%[24]. - The company’s investment income showed a significant decline of 501.01%, resulting in a loss of ¥6,049,434.19[10]. - The company reported a net investment loss of ¥6,049,434.19 compared to a gain of ¥1,508,551.44 in the previous period[24]. - The company experienced a credit impairment loss of CNY -12,578,990.17, worsening from CNY -10,237,654.36 in the previous year[25].

Financial Performance - The company's operating revenue for Q3 2025 reached ¥158,856,751.58, representing an increase of 82.32% compared to the same period last year[5] - Net profit attributable to shareholders was ¥21,793,062.71, a significant increase of 151.37% year-on-year[5] - The basic earnings per share for the period was ¥0.19, reflecting a growth of 171.43% compared to the previous year[5] - The company reported a 47.27% increase in total operating income for the first nine months of 2025, totaling ¥386,864,932.74[8] - Total operating revenue for the current period reached ¥386,864,932.74, a significant increase from ¥262,687,376.80 in the previous period, representing a growth of approximately 47.3%[22] - Net profit for the period was ¥66.94 million, up from ¥33.47 million, marking a 99.5% increase compared to the previous year[24] - Basic and diluted earnings per share rose to ¥0.56 from ¥0.31, reflecting an increase of 80.6%[24] - The company reported a total comprehensive income of ¥66.94 million, up from ¥33.47 million, indicating a 99.5% increase[24] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥1,478,644,197.18, marking a 13.07% increase from the end of the previous year[5] - The company's total assets as of September 30, 2025, amounted to ¥1,478,644,197.18, up from ¥1,307,716,972.03 at the beginning of the period, indicating an increase of about 13.1%[20] - Current assets totaled ¥962,736,120.83, compared to ¥828,084,079.65 at the start of the period, reflecting a growth of approximately 16.2%[19] - The company's total liabilities increased to ¥396,653,258.17 from ¥286,754,130.97, marking a rise of about 38.3%[20] - The equity attributable to the parent company reached ¥1,053,554,487.87, compared to ¥1,003,757,215.64 at the beginning of the period, showing an increase of approximately 4.9%[20] Accounts Receivable and Inventory - Accounts receivable increased by 34.39% to ¥314,578,217.87, primarily due to business growth[8] - Accounts receivable rose to ¥314,578,217.87 from ¥234,085,676.99, representing an increase of about 34.4%[19] - Inventory levels rose by 55.04% to ¥133,898,797.58, indicating increased stock to support sales[8] - Inventory levels increased to ¥133,898,797.58 from ¥86,364,421.24, indicating a growth of approximately 55.0%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,575[10] - The largest shareholder, Li Wenxi, holds 25.98% of the shares, with 30,556,400 shares, of which 22,917,300 are under freeze[10] - The top 10 unrestricted shareholders hold a total of 22,917,300 shares, with Li Wenxi being the largest shareholder at 7,639,100 shares, representing 2.21% of total shares[11] - The company has a total of 16,369,500 restricted shares at the beginning of the period, with 6,547,800 shares released during the period, resulting in 22,917,300 restricted shares at the end of the period[13] - The shareholder Chen Sili holds 2,195,550 shares, which is 1.31% of the total shares, with no restrictions on these shares[11] - The company has a total of 2,466,900 shares held by Shanghai A Xing Investment Management Co., which represents 2.10% of total shares[11] - The shareholder Wang Chao Xiang holds 2,042,420 shares, accounting for 1.74% of total shares[11] - The company has a total of 1,680,000 shares held by Zhongshan Honghua Equity Investment Management Center, representing 1.43% of total shares[11] - The total number of shares held by the top 10 unrestricted shareholders is 22,917,300, which is a significant portion of the company's equity[11] - The company has a total of 1,453,480 shares held by Zhu Lingling, which is 1.24% of total shares[11] - The shareholder Jiao Wenhui holds 856,100 shares, accounting for 0.73% of total shares[11] - The shareholder Tao Yanan holds 731,000 shares, representing 0.62% of total shares[11] Cash Flow and Expenses - Cash flow from operating activities generated ¥31.98 million, a decrease from ¥34.93 million in the previous year[25] - Cash inflow from investment activities was ¥29.78 million, down from ¥96.76 million year-over-year[26] - Cash flow from financing activities resulted in a net outflow of ¥31.48 million, compared to a net inflow of ¥2.18 million in the previous year[27] - The company received cash from sales of goods and services amounting to ¥202.94 million, compared to ¥161.45 million in the previous year[25] - The company’s cash and cash equivalents at the end of the period totaled ¥383.64 million, slightly up from ¥379.11 million[27] - The company's cash and cash equivalents decreased slightly to ¥394,144,567.81 from ¥404,373,272.63, a decline of about 2.9%[18] - The company’s management expenses increased by 32.65% to ¥48,913,664.40, mainly due to higher personnel costs[8] - Total operating costs increased to ¥329.72 million from ¥236.69 million, representing a 39.2% increase year-over-year[23] Legal Matters - The company is currently involved in a legal dispute regarding a divorce case involving its actual controller, which may have implications for its governance[16] Audit Information - The company did not undergo an audit for the third quarter financial report[28]

Financial Performance - In Q3 2025, the company achieved operating revenue of CNY 2.82 billion, a year-on-year increase of 14.25%[5] - The net profit attributable to shareholders in Q3 2025 was CNY 249.22 million, representing a year-on-year growth of 58.35%[11] - The company’s cumulative operating revenue for the first nine months of 2025 reached CNY 8.27 billion, up 17.47% compared to the same period last year[5] - The net profit attributable to shareholders for the first nine months of 2025 was CNY 602.90 million, an increase of 69.66% year-on-year[11] - The gross profit margin in Q3 2025 improved by 2.45% year-on-year and 2.99% quarter-on-quarter, indicating a positive trend[9] - Total operating revenue for the current period reached ¥8,269,626,721.45, an increase of 17.5% compared to ¥7,040,064,327.96 in the previous period[28] - Net profit for the current period was ¥642,329,753.59, representing a 97.5% increase from ¥325,309,428.57 in the previous period[29] - Earnings per share (EPS) for the current period was ¥0.6517, compared to ¥0.3814 in the previous period, reflecting a significant growth[30] - The total comprehensive income for the current period was ¥594,584,786.81, compared to ¥313,367,251.61 in the previous period, showing a growth of 89.9%[30] Cash Flow and Financial Management - The net cash flow from operating activities for the first nine months of 2025 increased by 34.19% year-on-year, reaching CNY 441.22 million[12] - Net cash flow from operating activities increased by 34.19% to 441,224,621.04, attributed to higher order volumes and improved cash management[17] - Operating cash inflow for the current period reached ¥7,650,962,750.67, an increase of 18.5% compared to ¥6,454,667,223.81 in the previous period[31] - Cash outflow from investment activities totaled ¥1,228,202,116.16, compared to ¥1,069,293,335.85 in the previous period, resulting in a net cash flow from investment activities of -¥521,851,824.46[32] - Cash inflow from financing activities was ¥1,577,989,549.66, down 18.6% from ¥1,938,902,700.37 in the previous period[32] - Net cash flow from financing activities was ¥151,854,454.47, a decrease of 56.7% compared to ¥350,586,011.89 in the previous period[32] - The ending balance of cash and cash equivalents increased to ¥1,108,089,421.00 from ¥895,952,102.20, reflecting a positive change in liquidity[32] - The company received cash from the recovery of investments amounting to ¥698,353,119.66, significantly higher than ¥136,980,301.95 in the previous period[32] Investments and Strategic Focus - The company is focusing on strategic upgrades through investments and acquisitions, particularly in high-growth areas like robotics[8] - The company has implemented cost reduction measures across production processes, enhancing operational efficiency and profit margins[8] - Trading financial assets increased by 93,290.19% to 269,057,151.51 from 288,100 due to increased investments in financial products[13] - Construction in progress rose by 52.65% to 404,659,228.81, driven by investments in multiple new projects[13] - Research and development expenses increased by 36.81% to 155,099,970.36, reflecting the company's commitment to innovation[13] - Research and development expenses for the current period were ¥473,430,805.70, an increase of 17.1% compared to ¥404,277,386.91 in the previous period[28] Balance Sheet and Assets - The company's total assets increased to CNY 12,768,868,008.18 as of September 30, 2025, up from CNY 11,970,554,542.52 at the beginning of the period, representing a growth of approximately 6.67%[24] - Current assets rose to CNY 8,046,152,164.77, compared to CNY 7,364,292,321.30 at the start of the period, indicating an increase of about 9.26%[24] - Cash and cash equivalents reached CNY 1,301,438,171.85, up from CNY 1,244,498,917.37, reflecting a growth of approximately 4.57%[24] - Accounts receivable increased to CNY 3,331,580,433.82 from CNY 2,871,306,826.75, marking a rise of about 16.03%[24] - Inventory decreased to CNY 2,189,550,722.59 from CNY 2,376,507,903.16, showing a decline of approximately 7.85%[25] - The company's non-current assets totaled CNY 4,722,715,843.41, up from CNY 4,606,262,221.22, which is an increase of about 2.53%[24] - The company's total liabilities decreased by 75.40% for short-term borrowings, optimizing the financing structure[13] - The total liabilities increased to ¥6,769,726,315.25 from ¥6,578,127,744.18, indicating a rise of 2.9%[27] - The company's long-term borrowings increased to ¥929,422,181.93 from ¥545,416,506.87, reflecting a rise of 70.4%[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 246,264, with the largest shareholder holding 15.00%[19] - The company repurchased and canceled 274,000 restricted shares at a price of CNY 7.5593 per share, which accounted for 0.0269% of the total share capital prior to the repurchase[21] - The company also repurchased and canceled 112,000 restricted shares at the same price due to the departure of four incentive targets, leading to a reduction in registered capital from CNY 924,806,285 to CNY 924,694,285[22] - The total number of shares decreased from 924,806,285 to 924,694,285 following the cancellation of the restricted shares[22]

中石化石油机械股份有限公司 2025 年第三季度报告 证券代码：000852 证券简称：石化机械 公告编号：2025-068 中石化石油机械股份有限公司 2025 年第三季度报告 本公司及除独立董事周京平外的董事会全体成员保证信息披露的内容真 实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 独立董事周京平因正在接受重庆市监察委员会监察调查，无法正常履行 职责，不能保证公告内容真实、准确、完整。 重要内容提示： 1.董事会、监事会及除独立董事周京平外的董事、监事、高级管理人员 保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗 漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人声明：保证季度 报告中财务信息的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一）主要会计数据和财务指标 | 项目 | 本报告期金额 | 年初至报告期 期末金额 | 说明 | | --- | --- | --- | --- | | 非流动性资产处置损益（包括已 | 54,794.51 | 156,588.94 | | | 计提资产减值准备的冲 ...

Financial Performance - Operating revenue for Q3 2025 was CNY 19,362,301, a decrease of 13.8% compared to the same period last year[2] - Net profit attributable to shareholders was CNY 30,595, representing a significant increase of 361.67% year-on-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 45,426, up 233.23% from the previous year[2] - Total operating revenue for the first three quarters of 2025 was RMB 58,885,527 thousand, a decrease of 10.5% compared to RMB 65,995,285 thousand in the same period of 2024[15] - The net profit for the first three quarters of 2025 was a loss of RMB 429,121 thousand, compared to a profit of RMB 39,916 thousand in the same period of 2024[16] - The company reported a comprehensive loss of RMB 441,723 thousand for the first three quarters of 2025, compared to a comprehensive income of RMB 48,476 thousand in 2024[16] Cash Flow - Cash flow from operating activities decreased by 81.28% to CNY 1,887,979 compared to the same period last year[3] - In the first three quarters of 2025, the net cash flow from operating activities was CNY 2,666,922,000, compared to CNY 10,425,601,000 in the same period of 2024, indicating a decrease of approximately 74.4%[19] - The total cash inflow from operating activities in 2025 was CNY 64,891,964,000, while cash outflow was CNY 62,225,042,000, resulting in a net cash inflow of CNY 2,666,922,000[19] - Cash inflow from investment activities decreased significantly from CNY 4,066,378,000 in 2024 to CNY 1,008,008,000 in 2025, a decline of about 75.2%[19] - The net cash flow from financing activities showed a negative balance of CNY 1,357,565,000 in 2025, compared to a negative CNY 2,402,408,000 in 2024, reflecting an improvement of approximately 43.5%[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 41,859,639, a slight increase of 0.22% from the end of the previous year[3] - The company's total assets as of September 30, 2025, amounted to RMB 41,859,639 thousand, slightly up from RMB 41,769,339 thousand at the end of 2024[12][13] - The total liabilities increased to RMB 17,489,796 thousand in 2025 from RMB 16,624,844 thousand in 2024, marking a rise of 5.2%[13] - The total equity attributable to shareholders of the parent company decreased to RMB 24,267,764 thousand from RMB 25,040,254 thousand, a decline of 3.1%[13] Shareholder Metrics - Basic and diluted earnings per share were both CNY 0.003, reflecting a 200.00% increase year-on-year[3] - The weighted average return on equity increased by 0.099 percentage points to 12.6%[3] - The company's earnings per share for the first three quarters of 2025 was -0.041 yuan, compared to 0.003 yuan in the same period of 2024[16] Government Support and Expenses - The company received government subsidies amounting to CNY 10,053, which positively impacted its financial performance[5] - Research and development expenses for the first three quarters of 2025 were RMB 211,024 thousand, an increase of 9.3% compared to RMB 193,894 thousand in 2024[15] Cash Management - Cash and cash equivalents decreased to RMB 9,642,801 thousand from RMB 12,096,477 thousand, a decline of 20.2%[12] - The total cash and cash equivalents increased by CNY 1,421,284,000 in 2025, compared to an increase of CNY 6,610,011,000 in 2024, indicating a significant reduction in cash growth[19] - The cash inflow from loans in 2025 was CNY 473,444,000, while in 2024 it was CNY 17,500,000,000, showing a drastic decrease of approximately 97.3%[19] - The cash outflow for debt repayment in 2025 was CNY 1,500,000,000, compared to CNY 19,700,000,000 in 2024, indicating a reduction of about 92.4%[19] - The cash inflow from other investment activities in 2025 was CNY 3,890,463,000, a significant drop from CNY 717,277,000 in 2024[19] - The cash flow from the disposal of fixed assets and other long-term assets increased from CNY 17,580,000 in 2024 to CNY 148,199,000 in 2025, marking an increase of approximately 742.5%[19] - The company did not report any cash inflow from the disposal of subsidiaries in 2025, while it recorded CNY 29,799,000 in 2024[19]

Financial Performance - The company's operating revenue for the third quarter reached ¥61,530.81 million, representing a year-on-year increase of 59.23%[3] - The net profit attributable to shareholders was ¥5,100.48 million, with a significant improvement from a loss to profit due to increased sales and cost reduction measures[10] - The basic earnings per share for the quarter was ¥0.06, with diluted earnings per share also at ¥0.06, indicating a recovery from previous losses[4] - Total operating revenue for the first three quarters of 2025 reached ¥1,536,926,021.13, a significant increase of 37.4% compared to ¥1,118,686,435.48 in the same period of 2024[21] - Operating profit for the first three quarters of 2025 was ¥74,206,043.22, recovering from a loss of ¥9,979,363.63 in the first three quarters of 2024[22] - Net profit for the first three quarters of 2025 was ¥62,934,646.33, compared to a net loss of ¥8,338,793.32 in the same period of 2024, indicating a turnaround in profitability[22] - Earnings per share for the first three quarters of 2025 were ¥0.07, recovering from a loss of ¥0.01 per share in the same period of 2024[23] Research and Development - Research and development expenses totaled ¥3,826.07 million, accounting for 6.22% of operating revenue, a decrease of 2.03 percentage points compared to the previous year[4] - Research and development expenses increased to ¥113,798,595.08 in the first three quarters of 2025, up from ¥92,611,641.43 in the same period of 2024, reflecting a focus on innovation[21] Assets and Liabilities - The total assets at the end of the reporting period were ¥943,768.19 million, reflecting a slight increase of 0.86% from the end of the previous year[4] - The company's current assets decreased to RMB 2,724,475,001.03 from RMB 2,955,667,140.99 in the previous year, reflecting a decline of approximately 7.8%[16] - Total liabilities decreased slightly to ¥4,747,634,838.07 in 2025 from ¥4,732,092,381.02 in 2024, indicating stable financial management[18] - Total equity attributable to shareholders increased to ¥4,690,047,072.81 in 2025 from ¥4,625,279,704.26 in 2024, showing growth in shareholder value[18] Cash Flow - The net cash flow from operating activities was negative at -¥4,079.34 million, a decline of 119.90% compared to the same period last year, primarily due to the timing of invoice settlements[10] - Operating cash inflow for the first three quarters of 2025 was CNY 1,328,550,623.34, a slight increase from CNY 1,319,362,620.39 in the same period of 2024[25] - Net cash flow from operating activities decreased significantly to CNY 33,903,088.41 compared to CNY 229,974,623.61 in the first three quarters of 2024[25] - Cash inflow from investment activities totaled CNY 1,713,646,834.74, down from CNY 3,069,339,087.96 in the previous year[26] - The ending cash and cash equivalents balance for the first three quarters of 2025 was CNY 882,997,165.55, down from CNY 973,902,441.61 in the same period of 2024[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,538, indicating a stable shareholder base[12] - The company has a major shareholder, China National Building Material Group Corporation, holding 33.16% of the total shares, which became fully tradable on October 9, 2025[14] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to enhance profitability and operational efficiency[10]